1,3-ditolylguanidine has been researched along with yohimbine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Defaux, JP; Junien, JL; Pascaud, X; Rozé, C | 1 |
Göthert, M; Jakschik, J; Likungu, J; Molderings, GJ | 1 |
2 other study(ies) available for 1,3-ditolylguanidine and yohimbine
Article | Year |
---|---|
Effect of selective sigma ligands on duodenal alkaline secretion in the rat.
Topics: Animals; Atropine; Bicarbonates; Dose-Response Relationship, Drug; Duodenum; Guanidines; Haloperidol; Injections, Intravenous; Intestinal Mucosa; Intestinal Secretions; Male; Naloxone; Phenazocine; Prazosin; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, sigma; Yohimbine | 1990 |
Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Aged; Animals; Anticonvulsants; Atrial Function; Binding Sites; Binding, Competitive; Electric Stimulation; Female; Guanidines; Heart Atria; Humans; Idazoxan; Imidazoles; Imidazoline Receptors; Isoindoles; Male; Middle Aged; Myocardium; Norepinephrine; Pulmonary Artery; Rabbits; Receptors, Adrenergic, alpha-2; Receptors, Drug; Tritium; Yohimbine | 1997 |